Relpax 20 Mg, 40 Mg And 80 Mg 20 mg, 40 mg and 80 mg Tablets
PDF Leaflet Revision Date: 23 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Acute treatment of migraine in adults and adolescents 18 years and older.
Dosage (summary)
Initial dose: 40 mg; max daily dose: 160 mg.
Onset of Action / Duration
Onset: 1.5 hours, Duration: 4 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; contraindicated in breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Serotonergic agents
Contraindications
- Hypersensitivity to eletriptan
- Severe hepatic impairment
- Uncontrolled hypertension
- Coronary heart disease
- Cerebrovascular accident
Common side effects
- Dizziness
- Palpitations
- Nausea
- Abdominal pain
Counselling Points
- Take at onset of migraine
- Do not exceed max dose
- Avoid in children under 18
Serious warnings
- Serotonin syndrome risk
- Increased blood pressure
- Not for atypical headaches
Important Disclaimer
The Relpax 20 Mg, 40 Mg And 80 Mg 20 mg, 40 mg and 80 mg Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
